Precision Therapeutics’ Subsidiary Helomics and National Alopecia Areata Foundation Sign Services Agreement to Provide Next-Generation Patient Registry for Alopecia Areata Research

    NEXT STORY
    Global Genital Herpes Treatment Drugs Market Study, 2019: Excellent Product Pipeline Catering Therapeutics Vaccines to Bolster Patient Immunity Such as GEN-003 and VCL-HB01
    PREV STORY
    Corbus Pharmaceuticals Announces Change of Primary Endpoint in Ongoing RESOLVE-1 Phase 3 Study in Systemic Sclerosis in U.S. to ACR CRISS from mRSS Following Meeting with FDA
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results

    author_avatar
    NASDAQ Market News

    XBiotech to Present Pivotal Phase 3 Data on Xilonix™ at European Society of Medical Oncology’s World Congress on Gastrointestinal Cancer

    First Time Pivotal Phase 3 Xilonix™ Data To Be Unveiled at Major Scientific CongressDeveloped ...

    author_avatar
    NASDAQ Market News

    Verona Pharma to Present Clinical Trial Data of Ensifentrine for COPD Maintenance Treatment at American Thoracic Society 2019 International Conference

    author_avatar
    NASDAQ Market News